Top compounds associated with response to LRRTM2


Feature Type Standardized
Nominal ANOVA
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.28 1e-10
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA CCT018159 GDSC1000 pan-cancer AAC 0.14 3e-05
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.18 0.0001
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.17 0.0002
mRNA indisulam CTRPv2 pan-cancer AAC 0.14 0.0005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.001
mRNA Rapamycin gCSI pan-cancer AAC -0.2 0.001
mRNA PD-0325901 gCSI pan-cancer AAC -0.18 0.001
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.14 0.001
Download CSV